1 / 10

CGMS Market

The global Continuous Glucose Monitoring Systems (CGMS) Market is predicted to reach USD 16.05 billion by 2030, registering a CAGR of 9.7% 2023 to 2030. CGM devices provides an easy and effective way to control diabetes.<br>

Chacha3
Download Presentation

CGMS Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CGMS Market: A Comprehensive Overview The global Continuous Glucose Monitoring Systems (CGMS) Market is predicted to reach USD 16.05 billion by 2030, registering a CAGR of 9.7% from 2023 to 2030. CGM devices provides an easy and effective way to control diabetes. Rise in incidences of diabetes worldwide, rising awareness in developing and underdeveloped economies, various advantages of CGMS devices over POC glucometers and underdeveloped economies, and technological advancements with major focus on developing CGMS devices majorly drive the continuous glucose monitoring systems market growth. However, lack of adequate reimbursement for such devices is acting as the key barrier to the wide scale adoption of these devices. © Next Move Strategy Consulting

  2. Agenda 1 2 Market Overview Segmentation A bird's-eye view of the CGM landscape. Breaking down the market by type and application. 3 4 Regional Analysis Key Players Focusing on key geographies and their unique dynamics. Profiling the major companies shaping the industry. © Next Move Strategy Consulting

  3. Market Overview The CGM market is experiencing substantial growth. This is driven by increasing diabetes prevalence and technological advancements. Demand is also rising due to patient awareness and ease of use. Tech Advances 2 1 Rising Adoption Diabetes Increase 3 © Next Move Strategy Consulting

  4. Market Segmentation The CGM market can be segmented by product type. This includes sensors, transmitters, and receivers. It is also segmented by application such as type 1, type 2 diabetes, and gestational diabetes. Product Type Application Sensors, Transmitters, Receivers Type 1, Type 2, Gestational Diabetes © Next Move Strategy Consulting

  5. Regional Analysis North America dominates the CGM market due to high healthcare expenditure. Asia Pacific is expected to witness significant growth. This is fueled by a large patient pool and increasing awareness. Europe and the Rest of the World also represent key markets. North America Asia Pacific Europe © Next Move Strategy Consulting

  6. Key Market Players The CGM market is highly competitive. Key players include Abbott Laboratories and Dexcom, Inc. A. Menarini Diagnostics and Echo Therapeutics are also significant players. Abbott Dexcom Menarini Echo © Next Move Strategy Consulting

  7. Key Market Players Other notable players in the CGM market include GlySens Incorporated and Johnson & Johnson. Medtronic Plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd. are also key companies. GlySens J&J Medtronic Roche © Next Move Strategy Consulting

  8. Key Highlights The CGM market is driven by innovation and partnerships. Miniaturization and integration with smart devices are key trends. Reimbursement policies and regulatory approvals also influence market growth. 1 Continuous advancements in sensor technology. Partnerships 2 Innovation Collaborations between device and data companies. 3 Regulatory Approvals and policies supporting market access. © Next Move Strategy Consulting

  9. Conclusion The CGM market presents significant opportunities for growth. This is driven by technological innovation and increasing demand. Stakeholders must focus on patient-centric solutions and strategic partnerships. Staying informed and adapting to market dynamics is crucial for success. © Next Move Strategy Consulting

  10. Thank You Follow Us www.nextmsc.com info@nextmsc.com +1-217-650-7991 Access Full Report : https://www.nextmsc.com/news/continuous-glucose-monitoring-systems-market © Next Move Strategy Consulting

More Related